BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 5, 2024
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
Jan. 27, 2016
View Archived Issues
Firm finds niche in cardiovascular monitoring: Irhythm finds its groove in both wearable, digital health markets
Read More
Hold placed on Califf nomination: Senate hostage-taking snares confirmation of FDA head
Read More
Ebola Lessons learned? Global organizations to speed Zika R&D
Read More
Financings: Minnetronix dips its toe in equity market with $20M raise
Read More
People in Places
Read More
Daily M&A: Perkinelmer completes acquisition of Vanadis
Read More
Agreements/contracts: Stereotaxis, Philips to continue cardiology procedure work
Read More
product briefs
Read More
Briefly noted
Read More
MDD's Oncology Extra
Read More
Funding to be used for host of trials: Cancer genomics firm Inivata pulls in $42M in series A funding
LONDON – Inivata Ltd. has raised £31.5 million (US$42.2 million) in a series A round, to advance the commercialization of its circulating tumor DNA liquid biopsy technology.
Read More
Inside the Beltway: NICE offers favorable review of AMS's Greenlight for BPH
Read More